- Home
- TSBK vs ELDN Comparison
TSBK vs ELDN Comparison
Compare TSBK & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- ELDN
- Stock Information
- Founded
- TSBK 1915
- ELDN 2004
- Country
- TSBK United States
- ELDN United States
- Employees
- TSBK N/A
- ELDN N/A
- Industry
- TSBK Banks
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- TSBK Finance
- ELDN Health Care
- Exchange
- TSBK Nasdaq
- ELDN Nasdaq
- Market Cap
- TSBK 242.0M
- ELDN 288.5M
- IPO Year
- TSBK 1998
- ELDN N/A
- Fundamental
- Price
- TSBK $30.80
- ELDN $4.29
- Analyst Decision
- TSBK
- ELDN Strong Buy
- Analyst Count
- TSBK 0
- ELDN 1
- Target Price
- TSBK N/A
- ELDN $16.00
- AVG Volume (30 Days)
- TSBK 9.0K
- ELDN 232.7K
- Earning Date
- TSBK 01-27-2025
- ELDN 03-27-2025
- Dividend Yield
- TSBK 3.25%
- ELDN N/A
- EPS Growth
- TSBK N/A
- ELDN N/A
- EPS
- TSBK 3.10
- ELDN N/A
- Revenue
- TSBK $75,328,000.00
- ELDN N/A
- Revenue This Year
- TSBK N/A
- ELDN N/A
- Revenue Next Year
- TSBK N/A
- ELDN N/A
- P/E Ratio
- TSBK $9.94
- ELDN N/A
- Revenue Growth
- TSBK N/A
- ELDN N/A
- 52 Week Low
- TSBK $23.93
- ELDN $1.52
- 52 Week High
- TSBK $33.98
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- TSBK 54.87
- ELDN 44.28
- Support Level
- TSBK $29.97
- ELDN $4.40
- Resistance Level
- TSBK $30.69
- ELDN $4.65
- Average True Range (ATR)
- TSBK 0.62
- ELDN 0.23
- MACD
- TSBK 0.03
- ELDN -0.04
- Stochastic Oscillator
- TSBK 63.88
- ELDN 8.16
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. Company also offers loans to real estate, including residential and commercial / multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans and land loans. The company mainly operates in the United States.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.